Team

300 agents do the analysis. People close the deal.

Agents scale the work. Trust in a transaction still runs through people. Our partners bring their own track record in capital raising and M&A, and direct access to owners, investors and family offices across DACH and Switzerland. Every mandate they bring in is executed on the full promerget.ai platform.

Founder & CEO

Johann Horch, founder and CEO of promerget GmbH

Founder & CEOpromerget GmbH

Johann Horch

Johann Horch is not your typical M&A advisor. He built niiio finance group AG (now etops group AG) from a regional SaaS startup into a publicly traded, pan-European WealthTech platform — €2M to €32M revenue in four years, 10+ acquisitions in three years, 300+ employees, successful exit. Then he left the industry to see it clearly.

Full profile →

Partner

Aladar Tepelea, Partner at promerget.ai

PartnerCapital Markets & M&A · promerget GmbH

Aladar Tepelea

Aladar began his career in Corporate Finance at Novartis, where he was involved in the USD 5.4 billion sale of the Animal Health division to Eli Lilly. At BlackRock, he focused on strategic M&A, FinTech innovation and business development. As interim CFO of Proxeus, he co-led a USD 25 million funding round. Since then, as founder, advisor, investor and board member, he has supported several seed and Series A financing rounds of his own and third-party ventures.

  • Fundraising · Seed to Series A
  • Strategic M&A
  • FinTech
  • Investor access
  • NovartisCorporate Finance. Divestment of the Animal Health division to Eli Lilly.
  • BlackRockBusiness Manager. Strategic M&A, FinTech innovation, business development.
  • ProxeusInterim CFO. Swiss blockchain venture; co-led a USD 25M funding round.
  • VenturesFounder, advisor, investor and board member. Seed and Series A rounds for own and third-party ventures.

Selected transactions

Roles as stated · figures from public announcements

Divestment · 2014/15 $5.4bn Sale of Novartis Animal Health to Eli Lilly and Company. All-cash transaction, closed 1 January 2015. Novartis Corporate Finance
Funding round · 2018 $25M Financing of Proxeus, Swiss Fintech Award winner 2018 (Early Stage Start-up of the Year). Interim CFO · co-lead
Venture financing Seed → A Several seed and Series A rounds for own and third-party ventures. Founder · advisor · investor · board

Access

Partners introduce owners of asset managers, private equity and venture investors, and entrepreneurs who are preparing a sale, an acquisition or a raise.

Execution

Every mandate runs through the promerget.ai process: ATLAS sources, NEXUS and CIPHER diligence, QUANTUM values, VECTOR matches buyers.

Accountability

Johann Horch leads the negotiation. One mandate, one team, one fee structure. No hand-offs between firms.

Three vehicles

Advisory and capital are kept apart on purpose.

  • ADVISORY & M&A

    promerget

    Mandates for a fee. Startup advisory at one end, the sale of the company at the other.

    Deal size €10M–€250M · max. 5 mandates per year

  • EARLY STAGE

    Horch Ventures

    Seed capital, own money, minority stakes. Charges no fees of any kind.

    First cheque €50k–€250k · pre-seed and seed

  • GROWTH

    Deutsche Tech Ventures

    Growth capital as a co-investor alongside a lead, with a long holding period.

    €250k–€1M · growth stage

Become a partner

We work with a small number of partners who bring their own track record in capital raising or M&A, and direct access to owners, investors and family offices. Every mandate a partner brings in is executed on the full promerget.ai platform.

Become a partner

Planning a sale, an acquisition or a raise? Talk to us.